Steen Meier Rønborg

Corporate Officer/Principal presso University of Copenhagen

70 anni

Commercial Services

Consumer Services

Profilo

Steen Meier Rønborg is the founder of Alsensa ApS, which was founded in 2000.
He held the title of Administrative Director from 2010 to 2012.
Currently, he is a Principal at the University of Copenhagen.
Dr. Rønborg has an undergraduate and doctorate degree from the University of Copenhagen.

Posizioni attive di Steen Meier Rønborg

Società	Posizione	Inizio
University of Copenhagen	Corporate Officer/Principal	03/07/2009

Tutte le posizioni attive di Steen Meier Rønborg

Precedenti posizioni note di Steen Meier Rønborg

Società	Posizione	Fine
Alsensa ApS Alsensa ApS Miscellaneous Commercial ServicesCommercial Services Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market.	Fondatore	15/04/2010

Vedi nel dettaglio l'esperienza di Steen Meier Rønborg

Formazione di Steen Meier Rønborg

University of Copenhagen

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Steen Meier Rønborg

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Alsensa ApS Alsensa ApS Miscellaneous Commercial ServicesCommercial Services Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market.	Commercial Services